Pfizer hair loss drug Litfulo approved in UK

Written by Ruchika Sharma Published On 2023-11-02T11:30:00+05:30 | Updated On 2 Nov 2023 5:15 PM IST

Pfizer hair loss drug Litfulo approved in UK

Alopecia areata is a condition where the immune system attacks hair follicles and causes hair to fall out, often in clumps.

Bengaluru: Britain's medicines regulator has approved Pfizer Inc's drug to treat hair loss caused by an autoimmune disease.

The drug, branded as Litfulo, has been approved by UK's Medicines and Healthcare products Regulatory Agency (MHRA) for people aged 12 years and older suffering from severe alopecia areata.

It has already been approved for use in Europe and the United States.

Read also: Pfizer Litfulo gets European Commission approval for adolescents, adults with severe alopecia areata

Alopecia areata is a condition where the immune system attacks hair follicles and causes hair to fall out, often in clumps

pfizerpfizer newsUSFDAhair loss druglitfuloalopecia areatahair loss

Source : Reuters

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751